WE-C-217BCD-06: In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nano-Graphene

PURPOSE

Our goal was to explore nano-graphene for in vivo tumor targeting and quantitatively evaluate the pharmacokinetics and tumor targeting efficacy through PET imaging, using ^{6 4} Cu and ⁶⁶ Ga as the radiolabel.

METHODS

Nano-graphene oxide (GO) sheets, with amino group- terminated PEG chains (10 kDa) covalently attached, were conjugated to NOTA (l,4,7-triazacyclononane-l,4,7-triacetic acid, a suitable chelator for ^{6 4} Cu and ^{6 6} Ga) and TRC105 (a mAb that binds to CD 105, overexpressed on neovasculature). FACS analyses, size measurements, and serum stability studies were performed to characterize the GO conjugates before in vivo investigation (PET, bio distribution, blocking studies, etc.) in 4T1 murine breast tumor-bearing mice. Findings from imaging studies were then validated by histology.

RESULTS

TRC105-conjugated GO, 20-30 nm in diameter, was specific for CD105 with little non-specific binding. Both ⁶⁴ Cu- and ⁶⁶ Ga- labled GO conjugates had excellent stability in mouse serum. Clearance of the GO conjugates in mice was via the hepatobiliary pathway. ^v Cu/^{6 6} Ga-NOTA-GO-TRC105 accumulated rapidly in the 4T1 tumor and tumor uptake remained stable over time (3.8±0.4, 4.5±0.4, 5.8±0.3, and 4.5±0.4 %ID/g at 0.5, 3, 7, and 24 h p.i. for⁶⁶ Ga; 5.8±0.6, 5.3±0.6, 4.0±0.4, and3.4±0.1 %ID/g at 0.5, 3,24, and 48 h p.i. for ^{6 4} Cu; n = 4). Blocking studies confirmed CD105 specificity of ^{6 4} Cu/^{6 6} Ga-NOTA- GOTRC105, which was corroborated by bio distribution studies. Furthermore, microscopy examination of GO in light view mode and immunofluorescence staining revealed that targeting of NOTA-GO-TRC105 is tumor vasculature CD105 specific with little extravasation.

CONCLUSIONS

For the first time, we demonstrated that GO can be specifically directed to the tumor neovasculature in vivo through targeting of CD105, a marker of tumor angiogenesis. The versatile chemistry of graphene-based nanomaterials makes them suitable nanoplatforms for future biomedical research, such as cancer theranostics.

WE-C-217BCD-04: Multimodality Imaging of Breast Cancer Experimental Lung Metastasis

PURPOSE

Metastatic breast cancer (MBC) is incurable. The clinical gold standard for assessing tumor microvessel density (MVD), an independent prognostic marker in MBC, is CD 105 staining. The goal of this study is to develop a positron emission tomography (PET)/near-infrared fluorescent (NIRF) probe for imaging of CD105 expression in MBC (i.e. non-invasive measurement of MVD), as well as other applications such as early detection of metastasis, intraoperative guidance, etc.

METHODS

TRC105, a chimeric anti-CD105 mAb, was dual-labeled with a NIRF dye and ⁸⁹ Zr to yield ^{8 9} Zr-Df-TRC105-800CW. Luciferase-transfected 4T1 murine breast cancer cells were injected intravenously into female BALB/c mice to establish a lung MBC model. Bio luminescence imaging (BLI) was carried out to non- invasively monitor the lung tumor burden. Comprehensive in vivo/ex vivo studies were performed to investigate ^{8 9} Zr-Df-TRC105-800CW in this MBC model. Cetuximab was used as an isotype-matched control.

RESULTS

Radiolabeled TRC105 has high tumor uptake in many tumor types in addition to MBC (e.g. pancreatic/prostate cancer and brain tumor), revealing broad clinical potential for TRC105-based agents. FACS analysis of HUVECs showed no difference in CD 105 binding between TRC105 and Df- TRC105-800CW. PET imaging revealed that 4T1 lung tumor uptake of ⁸⁹ Zr-Df-TRC105-800CW was 8.7±1.4,10.9±0.5, and 9.7±1.1 %ID/g at 4, 24, and 48 h post-injection (n = 4), with excellent tumor contrast. Bio distribution studies, blocking, control studies with ^{8 9} Zr-Df-cetuximab- 800CW, ex vivo BLI/PET/NIRF imaging, and histology all confirmed CD 105 specificity of the tracer. NIRF imaging-guided removal of 4T1 tumors with Df-TRC105-800CW in a subcutaneous model was also straightforward.

CONCLUSIONS

We report the first PET/NIRF imaging of CD105 expression in a MBC model. Broad clinical potential of TRC105- based agents was shown in many tumor types, which also enabled early detection of small metastases and provided intraoperative guidance for tumor removal.

Routine short-term ureteral stent in living donor renal transplantation: introduction of a simple stent removal technique without using anesthesia and cystoscope

OBJECTIVE

We evaluated routine short-time insertion of ureteral stent in living donor renal transplant at a single center. It was easy to remove the stent without cystoscopy and anesthesia.

MATERIALS AND METHODS

Between October 2007 and July 2010, a single surgeon performed 76 living donor renal transplantations at one institute. All recipients underwent extravesical ureteroneocystostomy with a 2-0 silk suture passed through the venting side hole of the double-J stent into the bladder; a quadruple knot prevented the suture's slippage or distraction from the stent. After removal of the indwelling catheter at 5 days posttransplantation, the 2-0 silk passed with the urinary stream within 72 hours. The double-J stent was removed at 7 to 10 (mean 8.4) days after kidney transplantation by pulling the 2-0 silk out of the urethral orifice without anesthesia or cystoscopy.

RESULTS

There was only one case of stenosis, which was resolved by surgery. No patient developed urinary leakage. There were three episodes of urinary tract infection in 70 patients during first 6 months' follow-up.

CONCLUSIONS

Routine short-term stenting is a safe and effective technique in living donor renal transplantation. Removal of the stent is feasible without cystoscopy or anesthesia.

Aptamers as therapeutics in cardiovascular diseases

With many advantages over other therapeutic agents such as monoclonal antibodies, aptamers have recently emerged as a novel and powerful class of ligands with excellent potential for diagnostic and therapeutic applications. Typically generated through Systematic Evolution of Ligands by EXponential enrichment (SELEX), aptamers have been selected against a wide range of targets such as proteins, phospholipids, sugars, nucleic acids, as well as whole cells. DNA/RNA aptamers are single-stranded DNA/RNA oligonucleotides (with a molecular weight of 5-40 kDa) that can fold into well-defined 3D structures and bind to their target molecules with high affinity and specificity. A number of strategies have been adopted to synthesize aptamers with enhanced in vitro/in vivo stability, aiming at potential therapeutic/diagnostic applications in the clinic. In cardiovascular diseases, aptamers can be developed into therapeutic agents as anti-thrombotics, anti-coagulants, among others. This review focuses on aptamers that were selected against various molecular targets involved in cardiovascular diseases: von Willebrand factor (vWF), thrombin, factor IX, phospholamban, P-selectin, platelet-derived growth factor, integrin α(v)β(3), CXCL10, vasopressin, among others. With continued effort in the development of aptamer-based therapeutics, aptamers will find their niches in cardiovascular diseases and significantly impact clinical patient management.

Aptamer-based fluorescent biosensors

Selected from random pools of DNA or RNA molecules through systematic evolution of ligands by exponential enrichment (SELEX), aptamers can bind to target molecules with high affinity and specificity, which makes them ideal recognition elements in the development of biosensors. To date, aptamer-based biosensors have used a wide variety of detection techniques, which are briefly summarized in this article. The focus of this review is on the development of aptamer-based fluorescent biosensors, with emphasis on their design as well as properties such as sensitivity and specificity. These biosensors can be broadly divided into two categories: those using fluorescently-labeled aptamers and others that employ label-free aptamers. Within each category, they can be further divided into "signal-on" and "signal-off" sensors. A number of these aptamer-based fluorescent biosensors have shown promising results in biological samples such as urine and serum, suggesting their potential applications in biomedical research and disease diagnostics.

Tumor-targeted drug delivery with aptamers

Cancer is one of the leading causes of death around the world. Tumor-targeted drug delivery is one of the major areas in cancer research. Aptamers exhibit many desirable properties for tumor-targeted drug delivery, such as ease of selection and synthesis, high binding affinity and specificity, low immunogenicity, and versatile synthetic accessibility. Over the last several years, aptamers have quickly become a new class of targeting ligands for drug delivery applications. In this review, we will discuss in detail about aptamer-based delivery of chemotherapy drugs (e.g. doxorubicin, docetaxel, daunorubicin, and cisplatin), toxins (e.g. gelonin and various photodynamic therapy agents), and a variety of small interfering RNAs. Although the results are promising which warrants enthusiasm for aptamer-based drug delivery, tumor homing of aptamer-based conjugates after systemic injection has only been achieved in one report. Much remains to be done before aptamer-based drug delivery can reach clinical trials and eventually the day-to-day management of cancer patients. Therefore, future directions and challenges in aptamer-based drug delivery are also discussed.

Molecular imaging with nucleic acid aptamers

With many desirable properties such as ease of synthesis, small size, lack of immunogenicity, and versatile chemistry, aptamers represent a class of targeting ligands that possess tremendous potential in molecular imaging applications. Non-invasive imaging of various disease markers with aptamer-based probes has many potential clinical applications such as lesion detection, patient stratification, treatment monitoring, etc. In this review, we will summarize the current status of molecular imaging with aptamer-based probes. First, fluorescence imaging will be described which include both direct targeting and activatable probes. Next, we discuss molecular magnetic resonance imaging and targeted ultrasound investigations using aptamer-based agents. Radionuclide-based imaging techniques (single-photon emission computed tomography and positron emission tomography) will be summarized as well. In addition, aptamers have also been labeled with various tags for computed tomography, surface plasmon resonance, dark-field light scattering microscopy, transmission electron microscopy, and surface-enhanced Raman spectroscopy imaging. Among all molecular imaging modalities, no single modality is perfect and sufficient to obtain all the necessary information for a particular question. Thus, a multimodality probe has also been constructed for concurrent fluorescence, gamma camera, and magnetic resonance imaging in vivo. Although the future of aptamer-based molecular imaging is becoming increasingly bright and many proof-of-principle studies have already been reported, much future effort needs to be directed towards the development of clinically translatable aptamer-based imaging agents which will eventually benefit patients.

Randomized clinical trial of laparoscopic anterior 180° partial versus 360° Nissen fundoplication: 5-year results

Anterior partial fundoplication (AF) has been popularized by a lower risk of mechanical side effects. The question then emerges whether anterior partial wrap has a similar antireflux effect with Nissen fundoplication (NF). We therefore conducted a randomized study to compare the long-term outcome of anterior fundoplication with NF. One hundred patients who enrolled in the trial from May 2003 to March 2005 were randomized to laparoscopic AF or laparoscopic NF. Endoscopy, pH monitoring, manometry, a detailed questionnaire, and a visual analog symptom score were completed preoperative at 6, 12, 24, and 60 months after surgical procedures. The postoperative adverse effects such as dysphagia and flatulence were compared between the two groups. Revision surgery or maintenance proton pump inhibitor therapy was defined as failure. Fifty procedures were performed in each group. The outcome at 5 years follow-up was determined for 96 patients (96%; 49 patients in the AF group and 47 in the NF group). Three patients (3%) died of unrelated causes during follow-up, and one patient changed address. Both fundoplications were found to provide good control of reflux-related symptoms in most of the patients. For 96 patients followed up more than 5 years, gastroesophageal reflux symptoms were well controlled in 81 patients (84.38%); the mean DeMeester scores in the AF group decreased from 106.89 ± 14.12 to 12.67 ± 3.14 and in the NF group from 109.51 ± 17.98 to 10.81 ± 2.65, and the esophagitis was ameliorated visibly. Moreover, there were significantly fewer patients in the AF group who complained of flatulence. Compared with NF, anterior 180° partial fundoplication is an effective treatment of gastroesophageal reflux and associates with fewer postoperative adverse effects.

Time reversal optical tomography: locating targets in a highly scattering turbid medium

A time reversal optical tomography (TROT) method for near-infrared (NIR) diffuse optical imaging of targets embedded in a highly scattering turbid medium is presented. TROT combines the basic symmetry of time reversal invariance and subspace-based signal processing for retrieval of target location. The efficacy of TROT is tested using simulated data and data obtained from NIR imaging experiments on absorptive and scattering targets embedded in Intralipid-20% suspension in water, as turbid medium. The results demonstrate the potential of TROT for detecting and locating small targets in a turbid medium, such as, breast tumors in early stages of growth.

Bayesian analysis of the effect of selection for residual feed intake on growth and feed intake curves in Yorkshire swine

Gompertz growth functions were fitted to longitudinal measurements of daily feed intake (DFI) and BW of 586 boars and 495 gilts from a selection experiment in Yorkshire pigs for residual feed intake (RFI). The selection experiment consists of a line selected for low residual feed intake (LRFI) for 5 generations and a randomly selected control line (CTRL). The objectives of this study were to use Bayesian methods to estimate genetic parameters of the Gompertz curve parameters for DFI and BW, to evaluate the effect of selection for reduced RFI on the Gompertz parameters and shape of curves for DFI and BW, and to develop methodology for quantifying genetic variation at the level of the original phenotypes for DFI and BW based on the Bayesian analysis of the nonlinear model. Separate analyses were done for boars and gilts and for BW and DFI. A hierarchical model was specified in 2 levels: in the first level, the Gompertz function was modeled for each pig, and at the second level, a 3-trait linear mixed model was fitted to the 3 Gompertz parameters (asymptotic value, inflection point, and decay parameter), with fixed effects of line by generation and random effects of additive genetic and environmental effects. Bayesian methods were used to combine the 2 levels of modeling. A total of 30,000 random samples of the posterior distributions after convergence of Markov chains were used for inference. Posterior means of heritability within the first level of the model for the asymptotic value, inflection point, and decay parameter for DFI were 0.74, 0.66, and 0.82 for boars and 0.79, 0.70, and 0.57 for gilts; corresponding estimates for BW were 0.64, 0.58, and 0.60 for boars and 0.46, 0.35, and 0.33 for gilts. For DFI, LRFI boars had a reduced mature DFI (2.91 vs. 3.20 kg/d) and an earlier inflection point (85 vs. 95 d) compared with CTRL boars. For BW, LRFI boars had a lighter mature BW (279 vs. 317 kg), an earlier inflection point (184 vs. 198 d), and a decreased decay parameter (127 vs. 134 d) compared with CTRL boars. In contrast, LRFI gilts had a later inflection point (225 vs. 200 d) and a greater decay parameter (172 vs. 143 d) than CTRL gilts for BW. The other Gompertz curve parameters for DFI and BW for boars and gilts were considered not different between lines, with posterior probabilities of the line differences being greater than zero ranging from 0.1 to 0.9.

Genetic analysis of longitudinal measurements of performance traits in selection lines for residual feed intake in Yorkshire swine

A 5-generation selection experiment in Yorkshire pigs for feed efficiency consists of a line selected for low residual feed intake (LRFI) and a random control line (CTRL). The objectives of this study were to use random regression models to estimate genetic parameters for daily feed intake (DFI), BW, backfat (BF), and loin muscle area (LMA) along the growth trajectory and to evaluate the effect of LRFI selection on genetic curves for DFI and BW. An additional objective was to compare random regression models using polynomials (RRP) and spline functions (RRS). Data from approximately 3 to 8 mo of age on 586 boars and 495 gilts across 5 generations were used. The average number of measurements was 85, 14, 5, and 5 for DFI, BW, BF, and LMA. The RRP models for these 4 traits were fitted with pen × on-test group as a fixed effect, second-order Legendre polynomials of age as fixed curves for each generation, and random curves for additive genetic and permanent environmental effects. Different residual variances were used for the first and second halves of the test period. The RRS models were fitted with the same fixed effects and residual variance structure as the RRP models and included genetic and permanent environmental random effects for both splines and linear Legendre polynomials of age. The RRP model was used for further analysis because the RRS model had erratic estimates of phenotypic variance and heritability, despite having a smaller Bayesian information criterion than the RRP model. From 91 to 210 d of age, estimates of heritability from the RRP model ranged from 0.10 to 0.37 for boars and 0.14 to 0.26 for gilts for DFI, from 0.39 to 0.58 for boars and 0.55 to 0.61 for gilts for BW, from 0.48 to 0.61 for boars and 0.61 to 0.79 for gilts for BF, and from 0.46 to 0.55 for boars and 0.63 to 0.81 for gilts for LMA. In generation 5, LRFI pigs had lower average genetic curves than CTRL pigs for DFI and BW, especially toward the end of the test period; estimated line differences (CTRL-LRFI) for DFI were 0.04 kg/d for boars and 0.12 kg/d for gilts at 105 d and 0.20 kg/d for boars and 0.24 kg/d for gilts at 195 d. Line differences for BW were 0.17 kg for boars and 0.69 kg for gilts at 105 d and 3.49 kg for boars and 8.96 kg for gilts at 195 d. In conclusion, selection for LRFI has resulted in a lower feed intake curve and a lower BW curve toward maturity.

Baifuzi reduces transient ischemic brain damage through an interaction with the STREX domain of BKCa channels

Stroke is a long-term disability and one of the leading causes of death. However, no successful therapeutic intervention is available for the majority of stroke patients. In this study, we explored a traditional Chinese medicine Baifuzi (Typhonium giganteum Engl.). We show, at first, that the ethanol extract of Baifuzi exerts neuroprotective effects against brain damage induced by transient global or focal cerebral ischemia in rats and mice. Second, the extract activated large-conductance Ca(2+)-activated K(+) channel (BK(Ca)) channels, and BK(Ca) channel blockade suppressed the neuroprotection of the extract, suggesting that the BK(Ca) is the molecular target of Baifuzi. Third, Baifuzi cerebroside (Baifuzi-CB), purified from its ethanol extract, activated BK(Ca) channels in a manner similar to that of the extract. Fourth, the stress axis hormone-regulated exon (STREX) domain of the BK(Ca) channel directly interacted with Baifuzi-CB, and its deletion suppressed channel activation by Baifuzi-CB. These results indicate that Baifuzi-CB activated the BK(Ca) channel through its direct interaction with the STREX domain of the channel and suggests that Baifuzi-CB merits exploration as a potential therapeutic agent for treating brain ischemia.

GaN-Based MSM uv Photodetectors

Results obtained from interdigital metal-semiconductor-metal (MSM) type of GaN based UV photodetectors are presented. MSM devices were fabricated using two types of GaN; high-resistive GaN and Mg doped GaN. For the high-resistive GaN detector, the lowest dark current is ∼0.1 nA and the UV responsivity of the device was about 460 AAV at a DC bias of 30 V. The Mg doped GaN exhibited large gains, 1150 A/W at 2.0 V, but at much higher dark currents, 400 nA. The high gain in this device is not well understood but was attributed to an ‘avalanche’ effect and is under investigation. It was found that the surface plasma treatment plays an important role in the device performance. After an appropriate plasma treatment the detectors showed higher responsivity with lower dark current.

Effect of selection for residual feed intake on feeding behavior and daily feed intake patterns in Yorkshire swine

Residual feed intake (RFI) is a measure of feed efficiency defined as the difference between observed and predicted feed intake based on average requirements for growth and maintenance. The objective of this study was to evaluate the effect of selection for decreased RFI on feeding behavior traits and to estimate their relationships with RFI. Three data sets from the 4th and 5th generations of a selection experiment with a line selected for reduced RFI (LRFI) and a randomly selected control line (CTRL) were analyzed. Lines were mixed in pens of 16 and evaluated for feeding behavior traits obtained from a single-space electronic feeder over a growing period of ~3 mo before ~115 kg. The following traits were evaluated as averages over the entire test period and over the first and second half of the test period: number of visits per day and hour; occupation time per day, visit, and hour; feed intake (FI) per day, visit, and hour; and FI rate per visit. Models used included fixed effects of line and feeder, covariates of on-test age and FI per day, and random effects of pen, on-test group, sire, and litter. Repeated measures models were used to analyze feeding patterns during the day. The LRFI pigs had significantly less FI per day than CTRL pigs for all 3 data sets. With adjustment for FI per day, line differences of all traits were in the same direction for all 3 data sets but differed in significance and size. Feed intake per visit and hour and visits per day and hour did not differ between lines, but the trend was for LRFI pigs to have fewer visits, in particular during peak eating times. The LRFI pigs had a greater feeding rate and less occupation time per day, visit, and hour than CTRL pigs, but this was not significant for all data sets. Correlations of RFI with FI per day and visit and visits per day were positive. Average daily gain was positively correlated with FI per day and visit and occupation time per visit but negatively correlated with visits per day. Feed intake per day was positively correlated with backfat. In conclusion, feed efficiency may be affected by FI behavior because selection for decreased RFI has resulted in pigs that spend less time eating and eat faster.

ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation

Therapeutic plasma exchange (TPE) preconditioning with immunosuppressive therapy reduces ABO antibody titers, permitting engraftment of ABO-incompatible (ABO-I) kidney transplants. The posttransplant predictive role of ABO antibody titers for antibody-mediated rejection (AMR) is unknown. This retrospective study evaluated 46 individuals who received TPE to permit ABO-I kidney transplantation. ABO antibody titers were performed using donor-type indicator red cells. Seven individuals (15.2%) experienced clinical or subclinical AMR. There was no significant difference between recipient blood group, number of pretransplant TPE and baseline titer between those with and without AMR. At 1-2 weeks posttransplant the median titer was 64 (range 4 - 512) among individuals with AMR and 16 (range 2 - 256) among individuals without AMR. Total agglutination reactivity score was significantly higher among individuals with AMR (p = 0.046). The risk of AMR was significantly higher among individuals with an elevated posttransplant titer of >or=64 (p = 0.006). The sensitivity of an elevated posttransplant titer was 57.1% with a specificity of 79.5%. The positive predictive value was 33.3% and the negative predictive value was 91.2%. Most individuals with AMR have an elevated titer, however, the positive predictive value of a high titer for AMR is poor.

Gene expression in hypothalamus, liver, and adipose tissues and food intake response to melanocortin-4 receptor agonist in pigs expressing melanocortin-4 receptor mutations

Transcriptional profiling was used to identify genes and pathways that responded to intracerebroventricular injection of melanocortin-4 receptor (MC4R) agonist [Nle4, d-Phe7]-α-melanocyte stimulating hormone (NDP-MSH) in pigs homozygous for the missense mutation in the MC4R, D298 allele ( n = 12), N298 allele ( n = 12), or heterozygous ( n = 12). Food intake (FI) was measured at 12 and 24 h after treatment. All pigs were killed at 24 h after treatment, and hypothalamus, liver, and back-fat tissue was collected. NDP-MSH suppressed ( P < 0.004) FI at 12 and 24 h in all animals after treatment. In response to NDP-MSH, 278 genes in hypothalamus ( q ≤ 0.07, P ≤ 0.001), 249 genes in liver ( q ≤ 0.07, P ≤ 0.001), and 5,066 genes in fat ( q ≤ 0.07, P ≤ 0.015) were differentially expressed. Pathway analysis of NDP-MSH-induced differentially expressed genes indicated that genes involved in cell communication, nucleotide metabolism, and signal transduction were prominently downregulated in the hypothalamus. In both liver and adipose tissue, energy-intensive biosynthetic and catabolic processes were downregulated in response to NDP-MSH. This included genes encoding for biosynthetic pathways such as steroid and lipid biosynthesis, fatty acid synthesis, and amino acid synthesis. Genes involved in direct energy-generating processes, such as oxidative phosphorylation, electron transport, and ATP synthesis, were upregulated, whereas TCA-associated genes were prominently downregulated in NDP-MSH-treated pigs. Our data also indicate a metabolic switch toward energy conservation since genes involved in energy-intensive biosynthetic and catabolic processes were downregulated in NDP-MSH-treated pigs.

Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase

Current guidelines recommend antiviral therapy for chronic hepatitis B (CHB) patients with elevated alanine aminotransferase (ALT) and high viral load. Scant histological data exist for CHB patients with persistently normal ALT (PNALT) because disease progression is thought to be rare. To identify potential predictors of significant histology in the presence of PNALT, we compared the clinical characteristics and histology of Chinese CHB PNALT patients to those in patients with elevated ALT. Percutaneous liver biopsy was performed in 522 CHB patients with Chinese ethnicity who had not had antiviral treatment. Differences in age, ALT, viral load, hepatitis B e antigen (HBeAg) status and liver histology were compared between eligible PNALT (252) and elevated ALT (270) patients. Of the PNALT patients, 38.5% had normal liver histology, 25.4% had significant necroinflammation and/or fibrosis and 8.4% had established cirrhosis. Furthermore, histopathological differences between patients with high-normal ALT (0.5-1.0 x the upper limit of normal (ULN)) and low-normal ALT (≤ 0.5 x ULN) were evaluated. There was a significantly greater prevalence of histopathology in the high-normal group (40.0%) than in the low-normal group (16.6%) (P < 0.001). Multiple logistic regression identified that significant histopathology findings in PNALT patients correlated with age (P < 0.001) and ALT level (P < 0.001), with age >40 years and ALT >0.5 x ULN predicting significant histopathology. Our data indicate that liver biopsy is recommended in CHB patients >40 years of age, particularly when their ALT is 0.5-1.0 x ULN. The findings above provide evidence for indication of antiviral therapy in patients with PNALT and significant histopathological change.

Selection to reduce residual feed intake in pigs produces a correlated response in juvenile insulin-like growth factor-I concentration

Data from a selection experiment for residual feed intake (RFI) were used to estimate genetic correlations between measures of efficiency and performance traits with juvenile IGF-I, and to demonstrate direct and correlated responses to selection. The heritability of IGF-I was 0.28 +/- 0.06 and genetic correlations of IGF-I with feed intake (0.26 +/- 0.17), backfat (0.52 +/- 0.11), and feed conversion ratio (0.78 +/- 0.14) were moderate to large. The estimated and realized genetic correlations between RFI and IGF-I were 0.63 +/- 0.15 and 0.84. In contrast, genetic correlations between IGF-I and lifetime or test period growth did not differ (P > 0.05) significantly from zero (0.06 +/- 0.14 and -0.19 +/- 0.14). Selection for decreased RFI produced a direct response in RFI, as expected, and was accompanied by downward correlated responses in ADFI, juvenile IGF-I, backfat, and growth traits, listed in order of decreasing relative magnitude, and an increased loin muscle area. The correlated response in IGF-I to selection on RFI demonstrates that this physiological measure is genetically associated with efficiency, and is thus useful as an early information source to estimate genetic merit for efficiency before performance testing. Decreased juvenile IGF-I is associated with leaner, more efficient animals.